Federal Register / Vol. 85, No. 76 / Monday, April 20, 2020 / Notices 21889 Controlled substance Drug code Schedule Desomorphine ................................................................................................................................................................. 9055 I Dihydromorphine ............................................................................................................................................................. 9145 I Heroin .............................................................................................................................................................................. 9200 I Morphine-N-oxide ............................................................................................................................................................ 9307 I Normorphine .................................................................................................................................................................... 9313 I Tilidine ............................................................................................................................................................................. 9750 I Alpha-methylfentanyl ....................................................................................................................................................... 9814 I Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) ............................................................................... 9821 I Methamphetamine ........................................................................................................................................................... 1105 II Phenmetrazine ................................................................................................................................................................. 1631 II Methylphenidate .............................................................................................................................................................. 1724 II Amobarbital ...................................................................................................................................................................... 2125 II Pentobarbital .................................................................................................................................................................... 2270 II Secobarbital ..................................................................................................................................................................... 2315 II Glutethimide ..................................................................................................................................................................... 2550 II Phencyclidine ................................................................................................................................................................... 7471 II Phenylacetone ................................................................................................................................................................. 8501 II Codeine ........................................................................................................................................................................... 9050 II Dihydrocodeine ................................................................................................................................................................ 9120 II Diphenoxylate .................................................................................................................................................................. 9170 II Ecgonine .......................................................................................................................................................................... 9180 II Ethylmorphine .................................................................................................................................................................. 9190 II Hydrocodone ................................................................................................................................................................... 9193 II Levorphanol ..................................................................................................................................................................... 9220 II Meperidine ....................................................................................................................................................................... 9230 II Meperidine intermediate-B .............................................................................................................................................. 9233 II Meperidine intermediate-C .............................................................................................................................................. 9234 II Dextropropoxyphene, bulk (non-dosage forms) .............................................................................................................. 9273 II 14-Hydroxmorphone ........................................................................................................................................................ 9665 II Noroxymorphone ............................................................................................................................................................. 9668 II Sufentanil ......................................................................................................................................................................... 9740 II Fentanyl ........................................................................................................................................................................... 9801 II The company plans to import the pending applications according to of the requested registration, as listed controlled substances for sale to proposed regulations that, if finalized, provided in this notice. This notice does research facilities for drug testing and would govern the program of growing not constitute any evaluation or analysis. In reference to drug codes 7360 marihuana for scientific and medical determination of the merits of the (Marihuana) and 7370 research under DEA registration. application submitted. (Tetrahydrocannabinols) the company DATES: Registered bulk manufacturers of The applicant plans to manufacture plans to import a synthetic cannabidiol the affected basic class(es), and bulk active pharmaceutical ingredients and a synthetic tetrahydrocannabinols. applicants therefor, may file written (APIs) for product development and No other activities for these drug codes comments on or objections to the distribution to DEA-registered are authorized for this registration. issuance of the proposed registration on researchers. If the application for or before June 19, 2020. registration is granted, the registrant William T. McDermott, ADDRESSES: Written comments should would not be authorized to conduct Assistant Administrator. be sent to: Drug Enforcement other activity under this registration [FR Doc. 2020–08328 Filed 4–17–20; 8:45 am] Administration, Attention: DEA Federal aside from those coincident activities BILLING CODE 4410–09–P Register Representative/DPW 8701 specifically authorized by DEA Morrissette Drive, Springfield, Virginia regulations. DEA will evaluate the 22152. To ensure proper handling of application for registration as a bulk DEPARTMENT OF JUSTICE comments, please reference Docket No. manufacturer for compliance with all Drug Enforcement Administration DEA–621 in all correspondence, applicable laws, treaties, and including attachments. regulations and to ensure adequate [Docket No. DEA–621] SUPPLEMENTARY INFORMATION: The safeguards against diversion are in place. Bulk Manufacturer of Controlled Controlled Substances Act (CSA) prohibits the cultivation and As this applicant has applied to Substances Application: Bulk distribution of marihuana except by become registered as a bulk Manufacturer of Marihuana: Groff NA persons who are registered under the manufacturer of marihuana, the Hemplex LLC CSA to do so for lawful purposes. In application will be evaluated under the ACTION: Notice of application. accordance with the purposes specified criteria of 21 U.S.C. 823(a). DEA in 21 CFR 1301.33(a), DEA is providing proposes to conduct this evaluation in SUMMARY: The Drug Enforcement notice that the entity identified below the manner described in the rule Administration (DEA) is providing has applied for registration as a bulk proposed at 85 FR 16292, published on notice of an application it has received manufacturer of schedule I controlled March 23, 2020, if finalized. from an entity applying to be registered substances. In response, registered bulk In accordance with 21 CFR to manufacture in bulk basic class(es) of manufacturers of the affected basic 1301.33(a), DEA is providing notice that controlled substances listed in schedule class(es), and applicants therefor, may on February 28, 2020, Groff NA I. DEA intends to evaluate this and other file written comments on or objections Hemplex LLC, 100 Redco Avenue, Suite VerDate Sep<11>2014 18:34 Apr 17, 2020 Jkt 250001 PO 00000 Frm 00068 Fmt 4703 Sfmt 4703 E:\FR\FM\20APN1.SGM 20APN1 jbell on DSKJLSW7X2PROD with NOTICES 21890 Federal Register / Vol. 85, No. 76 / Monday, April 20, 2020 / Notices